EP Patent

EP3944859A1 — Method for treating immune toxicities induced by immune checkpoint inhibitors

Assigned to Assistance Publique Hopitaux de Paris APHP · Expires 2022-02-02 · 4y expired

What this patent protects

The invention relates to the use of a JAK inhibitor for treating or preventing adverse events in patient treated with an immune checkpoint inhibitor, or for treating cancer in combination with an immune checkpoint inhibitor.

USPTO Abstract

The invention relates to the use of a JAK inhibitor for treating or preventing adverse events in patient treated with an immune checkpoint inhibitor, or for treating cancer in combination with an immune checkpoint inhibitor.

Drugs covered by this patent

Patent Metadata

Patent number
EP3944859A1
Jurisdiction
EP
Classification
—
Expires
2022-02-02
Drug substance claim
No
Drug product claim
No
Assignee
Assistance Publique Hopitaux de Paris APHP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.